IDSA GUIDELINES
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Executive Summary
Jump to Section
Aspergillus species have emerged as an important cause of life-threatening infections in immunocompromised patients. This expanding population is composed of patients with prolonged neutropenia, advanced HIV infection, and inherited immunodeficiency and patients who have undergone allogeneic hematopoietic stem cell transplantation (HSCT) and/or lung transplantation. This document constitutes the guidelines of the Infectious Diseases Society of America for treatment of aspergillosis and repla*** the practice guidelines for Aspergillus published in 2000 [1]. The objective of these guidelines is to summarize the current evidence for ...
非常抱歉，您的当前状态为游客，因此只能查阅部分内容。要查阅完整内容请
注册 或者
登录 。
